# ADR-001: Adoption of Playwright with TypeScript for UI & Synthetic Testing

```text
Status:        ACCEPTED
Date:          2026-08-29
Deciders:      QA Architect, SDET Lead, Principal Frontend Engineer
```

## Context
Mediverse requires a modern, resilient, cross-browser web and synthetic automation framework supporting Chromium, Firefox, and WebKit across desktop and mobile responsive viewports.

## Decision
Adopt **Microsoft Playwright (TypeScript)** as the primary enterprise standard for UI functional testing, regression testing, visual verification, and production synthetic monitoring.

## Rationale
- Native multi-tab, multi-origin, and iframe isolation with browser contexts.
- Auto-waiting mechanisms eliminating arbitrary static sleep timers.
- Built-in network mocking, route interception, and authentication state reuse.
- Native TypeScript type safety aligning directly with Next.js frontend codebases.
- Open-source, active ecosystem, zero license fees.

## Consequences
- Requires SDET and QA engineers to maintain TypeScript proficiency.
- Cypress and Selenium WebDriver will not be permitted for new test suites.
